- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Disc Medicine Inc (IRON)
Disc Medicine Inc stock price live, this page displays NASDAQ IRON stock exchange data. View the IRON premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Disc Medicine Inc real time stock price chart below.
What Is the Disc Medicine Inc Stock Price Today?
The Disc Medicine Inc stock price today is 59.76.
What Is the Stock Symbol for Disc Medicine Inc?
The stock symbol for Disc Medicine Inc is ""IRON.""
What Stock Exchange Does Disc Medicine Inc Trade On?
Disc Medicine Inc is listed and trades on the NASDAQ stock exchange.
Is Disc Medicine Inc a Good Stock to Buy?
Determining whether Disc Medicine Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRON quote. (ISIN: US2546041011)
What Is the Disc Medicine Inc Stock Price Today?
The Disc Medicine Inc stock price today is 59.76.
What Is the Stock Symbol for Disc Medicine Inc?
The stock symbol for Disc Medicine Inc is ""IRON.""
What Stock Exchange Does Disc Medicine Inc Trade On?
Disc Medicine Inc is listed and trades on the NASDAQ stock exchange.
Is Disc Medicine Inc a Good Stock to Buy?
Determining whether Disc Medicine Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRON quote. (ISIN: US2546041011)
NASDAQ
Currency in USD
59.76
+0.41(+0.69%)
Closed·
After Hours
60.09+0.33(+0.55%)
·
Fair Value
An estimate of a Disc Medicine's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
58.86
60.80
52 wk Range
30.82
68.73
IRON Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 7 days
More Info
Fair Value
An estimate of a Disc Medicine's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
58.8660.80
52 wk Range
30.8268.73
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IRON Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Disc Medicine's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
97.25
Upside
+62.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Disc Medicine Inc Company Profile
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.
Disc Medicine Inc SWOT Analysis
Pipeline Promise | Explore Disc Medicine's innovative treatments for rare blood disorders, including Bitopertin for EPP and DISC-0974 for anemia in myelofibrosis and chronic kidney disease |
Market Potential | Delve into the multi-billion dollar market opportunity for Disc Medicine's therapies, with analysts projecting peak sales of $3 billion for DISC-0974 alone |
Clinical Milestones | Learn about upcoming data releases and regulatory interactions that could significantly impact Disc Medicine's valuation, including a potential NDA filing by 2025 |
Analyst Optimism | Discover why analysts maintain a Strong Buy consensus, with price targets ranging from $75 to $118, reflecting confidence in Disc Medicine's pipeline and market prospects |
Compare IRON to Peers and Sector
Metrics to compare | IRON | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIRONPeersSector | |
|---|---|---|---|---|
P/E Ratio | −17.8x | −3.6x | −0.5x | |
PEG Ratio | 1.13 | 0.02 | 0.00 | |
Price/Book | 3.1x | 2.3x | 2.6x | |
Price / LTM Sales | - | 9.7x | 3.2x | |
Upside (Analyst Target) | 50.8% | 184.6% | 43.8% | |
Fair Value Upside | Unlock | 15.3% | 8.1% | Unlock |
Analyst Ratings
13 Buy
0 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 97.25
(+62.73% Upside)
Earnings
Latest Release
May 07, 2025
EPS / Forecast
-1.02 / -1.14
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Disc Medicine Trade On?
Disc Medicine is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Disc Medicine?
The stock symbol for Disc Medicine is "IRON."
What Is the Disc Medicine Market Cap?
As of today, Disc Medicine market cap is 2.07B.
What Is Disc Medicine's Earnings Per Share (TTM)?
The Disc Medicine EPS (TTM) is -3.92.
When Is the Next Disc Medicine Earnings Date?
Disc Medicine will release its next earnings report on 07 Aug 2025.
From a Technical Analysis Perspective, Is IRON a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Disc Medicine Stock Split?
Disc Medicine has split 1 times.
How Many Employees Does Disc Medicine Have?
Disc Medicine has 94 employees.
What is the current trading status of Disc Medicine (IRON)?
As of 01 Aug 2025, Disc Medicine (IRON) is trading at a price of 59.76, with a previous close of 59.76. The stock has fluctuated within a day range of 58.86 to 60.80, while its 52-week range spans from 30.82 to 68.73.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.